99 related articles for article (PubMed ID: 28140712)
1. The clinical characteristics and prognostic significance of AID, miR-181b, and miR-155 expression in adult patients with de novo B-cell acute lymphoblastic leukemia.
Zhou G; Cao Y; Dong W; Lin Y; Wang Q; Wu W; Hua X; Ling Y; Xie X; Hu S; Cen J; Gu W
Leuk Lymphoma; 2017 Sep; 58(9):1-9. PubMed ID: 28140712
[TBL] [Abstract][Full Text] [Related]
2. Upregulation of microRNA-21 is a poor prognostic marker in patients with childhood B cell acute lymphoblastic leukemia.
Labib HA; Elantouny NG; Ibrahim NF; Alnagar AA
Hematology; 2017 Aug; 22(7):392-397. PubMed ID: 28253825
[TBL] [Abstract][Full Text] [Related]
3. Downregulated expression of miR-155, miR-17, and miR-181b, and upregulated expression of activation-induced cytidine deaminase and interferon-α in PBMCs from patients with SLE.
Kaga H; Komatsuda A; Omokawa A; Ito M; Teshima K; Tagawa H; Sawada K; Wakui H
Mod Rheumatol; 2015; 25(6):865-70. PubMed ID: 25775145
[TBL] [Abstract][Full Text] [Related]
4. Aberrant activation-induced cytidine deaminase expression in Philadelphia chromosome-positive B-cell acute lymphoblastic leukemia.
Shi Y; Zhao X; Durkin L; Rogers HJ; Hsi ED
Hum Pathol; 2016 Jun; 52():173-8. PubMed ID: 26980048
[TBL] [Abstract][Full Text] [Related]
5. Prognostic significance of MSI2 predicts unfavorable outcome in adult B-acute lymphoblastic leukemia.
Aly RM; Ghazy HF
Int J Lab Hematol; 2015 Apr; 37(2):272-8. PubMed ID: 25090928
[TBL] [Abstract][Full Text] [Related]
6. Different isoforms of the B-cell mutator activation-induced cytidine deaminase are aberrantly expressed in BCR-ABL1-positive acute lymphoblastic leukemia patients.
Iacobucci I; Lonetti A; Messa F; Ferrari A; Cilloni D; Soverini S; Paoloni F; Arruga F; Ottaviani E; Chiaretti S; Messina M; Vignetti M; Papayannidis C; Vitale A; Pane F; Piccaluga PP; Paolini S; Berton G; Baruzzi A; Saglio G; Baccarani M; Foà R; Martinelli G
Leukemia; 2010 Jan; 24(1):66-73. PubMed ID: 19759560
[TBL] [Abstract][Full Text] [Related]
7. Activation-induced cytidine deaminase acts as a mutator in BCR-ABL1-transformed acute lymphoblastic leukemia cells.
Feldhahn N; Henke N; Melchior K; Duy C; Soh BN; Klein F; von Levetzow G; Giebel B; Li A; Hofmann WK; Jumaa H; Müschen M
J Exp Med; 2007 May; 204(5):1157-66. PubMed ID: 17485517
[TBL] [Abstract][Full Text] [Related]
8. [Expression and Clinical Significance of Exosome Derived MiR-181b-5p in Children with Acute Lymphoblastic Leukemia].
Hong Y; Liu KK; Wang NL; Xie ZW; Chu JH
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2023 Jun; 31(3):643-648. PubMed ID: 37356920
[TBL] [Abstract][Full Text] [Related]
9. Down-regulation of microRNA-181b is a potential prognostic marker of non-small cell lung cancer.
Yang J; Liu H; Wang H; Sun Y
Pathol Res Pract; 2013 Aug; 209(8):490-4. PubMed ID: 23827213
[TBL] [Abstract][Full Text] [Related]
10. Histone deacetylase inhibitors upregulate B cell microRNAs that silence AID and Blimp-1 expression for epigenetic modulation of antibody and autoantibody responses.
White CA; Pone EJ; Lam T; Tat C; Hayama KL; Li G; Zan H; Casali P
J Immunol; 2014 Dec; 193(12):5933-50. PubMed ID: 25392531
[TBL] [Abstract][Full Text] [Related]
11. miR expression profiling at diagnosis predicts relapse in pediatric precursor B-cell acute lymphoblastic leukemia.
Avigad S; Verly IR; Lebel A; Kordi O; Shichrur K; Ohali A; Hameiri-Grossman M; Kaspers GJ; Cloos J; Fronkova E; Trka J; Luria D; Kodman Y; Mirsky H; Gaash D; Jeison M; Avrahami G; Elitzur S; Gilad G; Stark B; Yaniv I
Genes Chromosomes Cancer; 2016 Apr; 55(4):328-39. PubMed ID: 26684414
[TBL] [Abstract][Full Text] [Related]
12. C-myc protein expression in B-cell acute lymphoblastic leukemia, prognostic significance?
Allen A; Gill K; Hoehn D; Sulis M; Bhagat G; Alobeid B
Leuk Res; 2014 Sep; 38(9):1061-6. PubMed ID: 25060305
[TBL] [Abstract][Full Text] [Related]
13. High bone marrow miR-19b level predicts poor prognosis and disease recurrence in de novo acute myeloid leukemia.
Zhang TJ; Lin J; Zhou JD; Li XX; Zhang W; Guo H; Xu ZJ; Yan Y; Ma JC; Qian J
Gene; 2018 Jan; 640():79-85. PubMed ID: 29032147
[TBL] [Abstract][Full Text] [Related]
14. [Expression and Function of miR-181b in Diffuse Large B Cell Lymphoma].
He B; Zhu DX; Chao HY
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2018 Aug; 26(4):1111-1115. PubMed ID: 30111416
[TBL] [Abstract][Full Text] [Related]
15. [Expression Level and Target Gene Prediction of miR-181b in Patients with Chronic Lymphocytic Leukemia].
Kou Z; Liu H; Wang YC; Huang Q; Wang ZS; Gu ZNE; Lang T; Nie YL; An L; A ZL; Mu HBE; Zhang XY; Fu L; Ai HJ; Mao M; Wang XM; Li Y
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2020 Jun; 28(3):808-814. PubMed ID: 32552940
[TBL] [Abstract][Full Text] [Related]
16. Characterization of B- and T-lineage acute lymphoblastic leukemia by integrated analysis of MicroRNA and mRNA expression profiles.
Fulci V; Colombo T; Chiaretti S; Messina M; Citarella F; Tavolaro S; Guarini A; Foà R; Macino G
Genes Chromosomes Cancer; 2009 Dec; 48(12):1069-82. PubMed ID: 19760605
[TBL] [Abstract][Full Text] [Related]
17. DNA hypermethylation of tumor suppressor genes RASSF6 and RASSF10 as independent prognostic factors in adult acute lymphoblastic leukemia.
Younesian S; Shahkarami S; Ghaffari P; Alizadeh S; Mehrasa R; Ghavamzadeh A; Ghaffari SH
Leuk Res; 2017 Oct; 61():33-38. PubMed ID: 28869817
[TBL] [Abstract][Full Text] [Related]
18. Prognostic significance of copy number alterations in adolescent and adult patients with precursor B acute lymphoblastic leukemia enrolled in PETHEMA protocols.
Ribera J; Morgades M; Zamora L; Montesinos P; Gómez-Seguí I; Pratcorona M; Sarrà J; Guàrdia R; Nomdedeu J; Tormo M; Martínez-Lopez J; Hernández-Rivas JM; González-Campos J; Barba P; Escoda L; Genescà E; Solé F; Millá F; Feliu E; Ribera JM;
Cancer; 2015 Nov; 121(21):3809-17. PubMed ID: 26194343
[TBL] [Abstract][Full Text] [Related]
19. Infectious stimuli promote malignant B-cell acute lymphoblastic leukemia in the absence of AID.
Rodríguez-Hernández G; Opitz FV; Delgado P; Walter C; Álvarez-Prado ÁF; González-Herrero I; Auer F; Fischer U; Janssen S; Bartenhagen C; Raboso-Gallego J; Casado-García A; Orfao A; Blanco O; Alonso-López D; Rivas JL; Tena-Dávila SG; Müschen M; Dugas M; Criado FJG; Cenador MBG; Vicente-Dueñas C; Hauer J; Ramiro AR; Sanchez-Garcia I; Borkhardt A
Nat Commun; 2019 Dec; 10(1):5563. PubMed ID: 31804490
[TBL] [Abstract][Full Text] [Related]
20. Differential miRNA expression in childhood acute lymphoblastic leukemia and association with clinical and biological features.
de Oliveira JC; Scrideli CA; Brassesco MS; Morales AG; Pezuk JA; Queiroz Rde P; Yunes JA; Brandalise SR; Tone LG
Leuk Res; 2012 Mar; 36(3):293-8. PubMed ID: 22099053
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]